Rollbar Announces $6 Million in Series A Funding to Extend Platform to Cloud Native Customers
Oct 23, 2017 13:00 pm UTC| Business
SAN FRANCISCO, Oct. 23, 2017 -- Rollbar, provider of real-time error monitoring Software as a Service, announced today that the company has secured its $6 Million series A funding led by Bain Capital, with participation...
Oct 23, 2017 12:59 pm UTC| Business
SPARTANBURG, S.C., Oct. 23, 2017 -- CAB Financial Corporation (the “Corporation”) and Carolina Alliance Bank (OTCQX:CRLN) (the “Bank”) announced that, effective today, they have consummated their corporate...
Georgia DOT Selects Acrow Bridge Support System for Use During Northwest Corridor Project in Atlanta
Oct 23, 2017 12:57 pm UTC| Business
PARSIPPANY, N.J., Oct. 23, 2017 -- Acrow Bridge, a leading international bridge engineering and supply company, has announced that it designed and provided a temporary “straddle bent” support structure to the Georgia...
Oct 23, 2017 12:45 pm UTC| Business
PARSIPPANY, N.J., Oct. 23, 2017 -- Interpace Diagnostics Group (NASDAQ:IDXG), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology services for improved patient...
CEMTREX ANNOUNCES REVISED EXCHANGE OFFER FOR KEY TRONIC CORP. VALUED AT $11 PER SHARE
Oct 23, 2017 12:31 pm UTC| Business
Farmingdale, NY, Oct. 23, 2017 -- Cemtrex, Inc. (Nasdaq: CETX, CETXP, CETXW) today announced a revised exchange offer, valued substantially higher at $11 per share, to acquire Key Tronic Corporation (Nasdaq: KTCC) by...
NEWSTAR SCHEDULES RELEASE OF RESULTS FOR THE THIRD QUARTER OF 2017
Oct 23, 2017 12:31 pm UTC| Business
Boston, MA, Oct. 23, 2017 -- NewStar Financial, Inc. (“NewStar”) (NASDAQ:NEWS) announced today that it will report financial results for the third quarter of 2017 on Wednesday, November 1, 2017 before the markets open. ...
BeyondSpring Receives Two Grants in China to Further Develop Innovative Drug Pipeline
Oct 23, 2017 12:31 pm UTC| Business
NEW YORK, Oct. 23, 2017 -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced that the Company...